Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Rina Yarosh"'
Autor:
Adolfo Correa, Annie Green Howard, Kari E North, Jerome I Rotter, Stephen S Rich, Ulrike Peters, Zhe Wang, Michael Y Tsai, Penny Gordon-Larsen, Christie Ballantyne, Shia T Kent, Ruth J F Loos, Christy L Avery, Xiuqing Guo, Jie Yao, Yao Hu, Mariaelisa Graff, Paul S de Vries, Keri L Monda, Moa P Lee, Sofia F Dimos, Laura M Raffield, Anna F Ballou, Carolina G Downie, Christopher H Arehart, Zhaohui Du, Christopher R Gignoux, Jeffrey Haessler, Helina Kassahun, J Antonio G Lopez, Michael H Preuss, Shannon L Rhodes, Rina Yarosh, Charles L Kooperberg
Publikováno v:
Open Heart, Vol 10, Iss 2 (2023)
Introduction The independent and causal cardiovascular disease risk factor lipoprotein(a) (Lp(a)) is elevated in >1.5 billion individuals worldwide, but studies have prioritised European populations.Methods Here, we examined how ancestrally diverse s
Externí odkaz:
https://doaj.org/article/1a269fc98b7043cc85c2bdef81e77451
Autor:
Allyson M. Gregoire, Trang VoPham, Francine Laden, Rina Yarosh, Katie M. O'Brien, Dale P. Sandler, Alexandra J. White
Publikováno v:
Environment International, Vol 159, Iss , Pp 107028- (2022)
Background: Ambient ultraviolet (UV) radiation has been increasing due to climate change. While this may result in adverse health consequences such as an increased incidence of skin cancer, UV radiation is also a source of vitamin D, which has been h
Externí odkaz:
https://doaj.org/article/3988f5fce725485caac6621178bb82f4
Autor:
Tamera J. Lillemoe, Mara Rendi, Michaela L. Tsai, Monica Knaack, Rina Yarosh, Erin Grimm, Barbara Susnik, Janet Krueger, Susan Olet, Karen K. Swenson
Publikováno v:
International Journal of Breast Cancer, Vol 2021 (2021)
Objectives. The response to HER2-targeted neoadjuvant chemotherapy (NAC) in HER2-positive (+) breast cancer can be quantified using residual cancer burden (RCB) pathologic evaluation to predict relapse free/overall survival. However, more information
Externí odkaz:
https://doaj.org/article/bb78fc25820f448b871f0e9180395daa
Autor:
Hazel B. Nichols, Melissa G. House, Rina Yarosh, Sara Mitra, Mandy Goldberg, Kimberly A. Bertrand, A. Heather Eliassen, Graham G. Giles, Michael E. Jones, Roger L. Milne, Katie M. O’Brien, Julie R. Palmer, Sven Sandin, Walter C. Willett, Weiyao Yin, Dale P. Sandler, Anthony J. Swerdlow, Minouk J. Schoemaker
Publikováno v:
Breast Cancer Research and Treatment. 199:323-334
Autor:
Sarah H Koenigsberg, Mariaelisa Graff, Anna F Ballou, Carolina G Downie, Annie Green Howard, Moa P Lee, Kari E North, Laura M Raffield, Rina Yarosh, Penny Gordon-Larsen, Christy L Avery
Publikováno v:
Circulation. 147
Introduction: The aromatic amino acids tyrosine and phenylalanine may increase type 2 diabetes risk, but few studies have examined whether these critical molecular precursors exert additional phenotypic effects and whether these effects are independe
Autor:
Christy L Avery, Annie Green Howard, Harold H Lee, Moa P Lee, Anna F Ballou, Laura M Raffield, Rina Yarosh, Kari E North, Penny Gordon-Larsen, Misa Graff
Publikováno v:
Circulation. 145
Introduction: Experimental and observational evidence suggests that aberrant branched chain amino acid (BCAA; leucine, isoleucine, and valine) metabolism promotes insulin resistance and downstream disease, prompting interest in BCAA catabolism as a t
Autor:
Jessica Y. Islam, Rina Yarosh, Marlene Camacho-Rivera, Denise C. Vidot, Lisa P. Spees, Christopher W. Wheldon
Publikováno v:
Sexually transmitted diseases. 48(12)
BACKGROUND The U.S. Preventive Services Task Force updated hepatitis C virus (HCV) screening 2020 guidelines to target adults aged 18 to 79 years: a major shift from the prior focus on high-risk populations ("baby boomers" aged ≥55 years as of 2019
Autor:
Susan Olet, Tamera J. Lillemoe, Monica Knaack, Michaela L. Tsai, Janet Krueger, Mara Hester Rendi, Erin Grimm, Karen K. Swenson, Rina Yarosh, Barbara Susnik
Publikováno v:
International Journal of Breast Cancer, Vol 2021 (2021)
International Journal of Breast Cancer
International Journal of Breast Cancer
Objectives. The response to HER2-targeted neoadjuvant chemotherapy (NAC) in HER2-positive (+) breast cancer can be quantified using residual cancer burden (RCB) pathologic evaluation to predict relapse free/overall survival. However, more information
Autor:
Charles Kamen, Paul M. Barr, AnnaLynn M. Williams, Jackson Clark, Rina Yarosh, Clive S. Zent, Edwin van Wijngaarden, Carla Casulo, Michelle C. Janelsins
Publikováno v:
Journal of Clinical Oncology. 36:153-153
153 Background: CLL is an indolent lymphoma effecting aging populations. Early stage patients are assigned to active surveillance and only 10% of patients require treatment at diagnosis. Active surveillance for CLL may increase susceptibility to anxi